To confirm that the expression of the RNA-binding tat domain in the stgp70tat antigen is sufficient to induce tumor-specific effector CD8+ T cell responses, we vaccinated B6 mice with pCI, pCI/stgp70, or pCI/stgp70tat DNA. Here, CD8A is linked to neoplasm.